<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema" xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema" xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dct="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/" xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/" xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/" xmlns:cja="http://www.elsevier.com/xml/cja/schema" xmlns:ja="http://www.elsevier.com/xml/ja/schema" xmlns:bk="http://www.elsevier.com/xml/bk/schema" xmlns:ce="http://www.elsevier.com/xml/common/schema" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:cals="http://www.elsevier.com/xml/common/cals/schema" xmlns:tb="http://www.elsevier.com/xml/common/table/schema" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema" xmlns:xlink="http://www.w3.org/1999/xlink"><rdf:RDF><rdf:Description rdf:about="http://dx.doi.org/10.1016/j.phyplu.2021.100194"><dct:format>application/xml</dct:format><dct:title>Anti-obesity activity of polyherbal formulation Divya-Medohar-Vati by inhibition of pancreatic lipase activity and triglyceride translocation through enterocytes</dct:title><dct:creator>Acharya Balkrishna</dct:creator><dct:creator>Anamica Singh</dct:creator><dct:creator>Jagdeep Singh</dct:creator><dct:creator>Subarna Pokhrel</dct:creator><dct:creator>Kunal Bhattacharya</dct:creator><dct:creator>Anurag Varshney</dct:creator><dct:subject><rdf:Bag><rdf:li>Divya-Medohar-Vati</rdf:li><rdf:li>Orlistat</rdf:li><rdf:li>Anti-lipase activity</rdf:li><rdf:li>Enterocytes</rdf:li><rdf:li>Systemic translocation</rdf:li><rdf:li>Triglycerides</rdf:li></rdf:Bag></dct:subject><dct:description>Phytomedicine Plus 2 (2022). doi:10.1016/j.phyplu.2021.100194</dct:description><prism:aggregationType>journal</prism:aggregationType><prism:publicationName>Phytomedicine Plus</prism:publicationName><prism:copyright>&#169; 2021 The Author(s). Published by Elsevier B.V.</prism:copyright><dct:publisher>Elsevier B.V.</dct:publisher><prism:issn>2667-0313</prism:issn><prism:volume>2</prism:volume><prism:number>1</prism:number><prism:coverDisplayDate>February 2022</prism:coverDisplayDate><prism:doi>10.1016/j.phyplu.2021.100194</prism:doi><prism:url>http://dx.doi.org/10.1016/j.phyplu.2021.100194</prism:url><dct:identifier>doi:10.1016/j.phyplu.2021.100194</dct:identifier><bam:articleNumber>100194</bam:articleNumber><oa:openAccessInformation><oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus><oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2021-12-04T12:48:13Z</oa:openAccessEffective><oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#Author</oa:sponsorType></oa:sponsor><oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by-nc-nd/4.0/</oa:userLicense></oa:openAccessInformation><cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open access article under the CC BY-NC-ND license.</cp:licenseLine></rdf:Description></rdf:RDF><dp:document-properties><dp:aggregation-type>Journals</dp:aggregation-type><dp:version-number>S300.1</dp:version-number></dp:document-properties><ja:article docsubtype="fla" version="5.6" xml:lang="en"><ja:item-info><ja:jid>PHYPLU</ja:jid><ja:aid>100194</ja:aid><ce:article-number>100194</ce:article-number><ce:pii>S2667-0313(21)00176-7</ce:pii><ce:doi>10.1016/j.phyplu.2021.100194</ce:doi><ce:copyright type="other" year="2021">The Author(s)</ce:copyright></ja:item-info><ja:head><ce:title id="tte0002">Anti-obesity activity of polyherbal formulation Divya-Medohar-Vati by inhibition of pancreatic lipase activity and triglyceride translocation through enterocytes</ce:title><ce:author-group id="aut0001"><ce:author id="au0001" author-id="S2667031321001767-c8b8a0106f0e4b6d71e4c090ff4b37d9"><ce:given-name>Acharya</ce:given-name><ce:surname>Balkrishna</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/visualization">Visualization</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/supervision">Supervision</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref></ce:author><ce:author id="au0002" author-id="S2667031321001767-df2d8b59252a9006bb3d5973a525af8c"><ce:given-name>Anamica</ce:given-name><ce:surname>Singh</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/formal-analysis">Formal analysis</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0003" author-id="S2667031321001767-e938226ff873f49bd7c758af2203b909"><ce:given-name>Jagdeep</ce:given-name><ce:surname>Singh</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/formal-analysis">Formal analysis</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0004" author-id="S2667031321001767-59c3bca6963c8a60afd4635365a1901a"><ce:given-name>Subarna</ce:given-name><ce:surname>Pokhrel</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/formal-analysis">Formal analysis</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0005" author-id="S2667031321001767-576764abd3268f7561c99fa05a09f3fc"><ce:given-name>Kunal</ce:given-name><ce:surname>Bhattacharya</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/methodology">Methodology</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/data-curation">Data curation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/formal-analysis">Formal analysis</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing &#x2013; original draft</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/visualization">Visualization</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0006" author-id="S2667031321001767-905e307a68e5e88d1ad9685da4e6397f"><ce:given-name>Anurag</ce:given-name><ce:surname>Varshney</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing &#x2013; review &amp; editing</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/project-administration">Project administration</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/visualization">Visualization</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/supervision">Supervision</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref><ce:cross-ref refid="cor0001"><ce:sup loc="post">&#x204e;</ce:sup></ce:cross-ref><ce:e-address id="ead0001" type="email" xlink:href="mailto:anurag@prft.co.in">anurag@prft.co.in</ce:e-address></ce:author><ce:affiliation id="aff0001" affiliation-id="S2667031321001767-82398e251ddd167ec164b9a34ba6db6c"><ce:label>a</ce:label><ce:textfn id="cetextfn0001">Drug Discovery and Development Division, Patanjali Research Institute, NH-58, Haridwar, 249405, Uttarakhand, India</ce:textfn><sa:affiliation><sa:organization>Drug Discovery and Development Division</sa:organization><sa:organization>Patanjali Research Institute</sa:organization><sa:address-line>NH-58</sa:address-line><sa:city>Haridwar</sa:city><sa:state>Uttarakhand</sa:state><sa:postal-code>249405</sa:postal-code><sa:country>India</sa:country></sa:affiliation><ce:source-text id="staff0001">aDrug Discovery and Development Division, Patanjali Research Institute, NH-58, Haridwar, 249405, Uttarakhand, India</ce:source-text></ce:affiliation><ce:affiliation id="aff0002" affiliation-id="S2667031321001767-1b4335c418f536ebb53bc60c3e059e28"><ce:label>b</ce:label><ce:textfn id="cetextfn0002">Department of Allied and Applied Sciences, University of Patanjali, Patanjali Yog Peeth, Roorkee-Haridwar Road, Haridwar, 249 405, Uttarakhand, India</ce:textfn><sa:affiliation><sa:organization>Department of Allied and Applied Sciences</sa:organization><sa:organization>University of Patanjali</sa:organization><sa:address-line>Patanjali Yog Peeth, Roorkee-Haridwar Road</sa:address-line><sa:city>Haridwar</sa:city><sa:state>Uttarakhand</sa:state><sa:postal-code>249 405</sa:postal-code><sa:country>India</sa:country></sa:affiliation><ce:source-text id="staff0002">bDepartment of Allied and Applied Sciences, University of Patanjali, Patanjali Yog Peeth, Roorkee-Haridwar Road, Haridwar, 249 405, Uttarakhand, India</ce:source-text></ce:affiliation><ce:correspondence id="cor0001"><ce:label>&#x204e;</ce:label><ce:text id="cetext0001">Corresponding author at: Drug Discovery and Development Division, Patanjali Research Institute, NH-58, Haridwar, 249405, Uttarakhand, India.</ce:text><sa:affiliation><sa:organization>Drug Discovery and Development Division</sa:organization><sa:organization>Patanjali Research Institute</sa:organization><sa:address-line>NH-58</sa:address-line><sa:city>Haridwar</sa:city><sa:state>Uttarakhand</sa:state><sa:postal-code>249405</sa:postal-code><sa:country>India</sa:country></sa:affiliation></ce:correspondence></ce:author-group><ce:abstract id="abs0001" view="all" class="author"><ce:section-title id="cesectitle0001">Abstract</ce:section-title><ce:abstract-sec id="abss0001" role="background" view="all"><ce:section-title id="cesectitle0002">Background</ce:section-title><ce:simple-para id="spara008" view="all">Obesity is a modern-day epidemic affecting human lifestyle worldwide and originates from high fat-content food consumption. Traditional Ayurveda-based polyherbal medicine &#x2018;Divya-Medohar-Vati&#x2019; (DMV) has been recommended as an anti-obesity formulation.</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0002" role="materials-methods" view="all"><ce:section-title id="cesectitle0003">Methods</ce:section-title><ce:simple-para id="spara009" view="all">In the present study, we explored the anti-obesity activity of DMV using biochemical assay, simulated gastrointestinal tract (GIT) digestion model, and Caco-2-derived enterocyte model. We further correlated the observed biological activity of DMV with its phytochemical profile determined using the high-performance-liquid-chromatography method.</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0003" role="results" view="all"><ce:section-title id="cesectitle0004">Results</ce:section-title><ce:simple-para id="spara010" view="all">Phytochemicals such as Gallic acid, Ellagic acid, Chebulic acid, Picroside I, and Arjungenin were identified in DMV. DMV and &#x2018;Orlistat&#x2019; (positive control) showed half-maximal inhibitory concentrations (IC<ce:inf loc="post">50</ce:inf>) of 647.88 and 21.80&#160;&#181;g/ ml, respectively against porcine pancreatic lipase activity. Addition of DMV and Orlistat to full cream during simulated GIT digestion reduced the hydrolysis of triglyceride into long-chain Palmitic acids and glycerol molecules in obtained digestae. At the same time, both DMV and Orlistat stimulated the release of medium-chained Capric acids in full cream digestae. Treatment of enterocytes with DMV-induced a loss of cell viability (IC<ce:inf loc="post">50</ce:inf> at 308.5&#160;&#x03bc;g/ml). Translocation of re-esterified triglycerides by enterocytes grown on transwell plate following treatment with full cream digestae was inhibited after the addition of DMV and Orlistat.</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0004" role="conclusion" view="all"><ce:section-title id="cesectitle0005">Conclusions</ce:section-title><ce:simple-para id="spara011" view="all">Taken together, DMV showed good inhibition for pancreatic lipase activity, and hydrolysis of triglycerides modulating the release of free glycerol and dietary fatty acid (Capric acid and Palmitic acid) contents. DMV also reduces the translocation of triglycerides through the basal region of enterocytes. Hence, Divya-Medohar-Vati was found to be an effective anti-obesity polyherbal formulation.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords id="keys0001" view="all" class="keyword"><ce:section-title id="cesectitle0006">Keywords</ce:section-title><ce:keyword id="key0001"><ce:text id="cetext0002">Divya-Medohar-Vati</ce:text></ce:keyword><ce:keyword id="key0002"><ce:text id="cetext0003">Orlistat</ce:text></ce:keyword><ce:keyword id="key0003"><ce:text id="cetext0004">Anti-lipase activity</ce:text></ce:keyword><ce:keyword id="key0004"><ce:text id="cetext0005">Enterocytes</ce:text></ce:keyword><ce:keyword id="key0005"><ce:text id="cetext0006">Systemic translocation</ce:text></ce:keyword><ce:keyword id="key0006"><ce:text id="cetext0007">Triglycerides</ce:text></ce:keyword></ce:keywords></ja:head></ja:article></doc:document>
